Baclofen
CAS 1134-47-0 18 FDA-DMF suppliersSmall Molecule
Overview
Baclofen is a centrally acting skeletal muscle relaxant and an antispastic agent, primarily used for the treatment of spasticity. It functions as a GABA_B receptor agonist, which helps reduce muscle spasms and is commonly used in cases of multiple sclerosis, spinal cord injuries, or diseases.
API suppliers (16)
Suppliers of Baclofen backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.
- PCASFrance1 active DMF
- PCASFrance1 active DMF
- FINE CHEMICALS CORP PTY LTD1 active DMF
- MATRIX PHARMACORP PRIVATE LTD1 active DMF
- EXCELLA GMBH AND CO KG1 active DMF
- PCASFrance1 active DMF
- FINE CHEMICALS CORP PTY LTD1 active DMF
- MATRIX PHARMACORP PRIVATE LTD1 active DMF
- Zakłady Farmaceutyczne Polpharma S.A.Poland1 active DMF
- MATRIX PHARMACORP PRIVATE LTD1 active DMF
- Zakłady Farmaceutyczne Polpharma S.A.Poland1 active DMF
- MATRIX PHARMACORP PRIVATE LTD1 active DMF
- RESOLUTION CHEMICALS LTD
- ICFI SPA
- ERREGIERRE SPAItaly
- PFC ITALIANA SRL DIV ALFA CHEMICALS ITALIANA
Patent & exclusivity (US)
Per the FDA Orange Book (74 approved US products), the latest listed US patent on Baclofen expires 28 Sept 2037. Generic API sourcing typically opens up once these lapse.
Therapeutic areas
NeurologyMuscular Disorders
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.